Mangalam Drugs

{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.37",
    "chg": 1.54,
    "chgp": "5.0%",
    "dir": 1,
    "prev_price": "30.83",
    "mcapval": "51.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Mar 06",
    "curr_time": "",
    "bse_nse_vol": "67.84 k",
    "exc_status": "Active",
    "traded_date": "Mar 06, 2026",
    "traded_date_str": "2026 03 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3875412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_upper_circuit_3875412.png",
        "date": "2026-03-06 10:00:07",
        "description": "Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 6 Mar 2026, hitting the upper circuit limit of 5%, closing at ₹32.26. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and regulatory trading restrictions."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3873109",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_mojoScore_3873109.png",
        "date": "2026-03-05 10:10:37",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3873260",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_upper_circuit_3873260.png",
        "date": "2026-03-05 10:00:06",
        "description": "Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 5 Mar 2026, hitting the upper circuit limit of 5% to close at ₹30.73. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and a regulatory freeze on further price movement."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3869286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_upper_circuit_3869286.png",
        "date": "2026-03-04 11:00:04",
        "description": "Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 4 Mar 2026, hitting the upper circuit limit of 5% and closing at ₹29.25. This sharp rally was driven by intense buying interest, resulting in a maximum daily gain of 4.97%, significantly outperforming its sector and benchmark indices despite opening with a gap down."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3863948",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_lower_circuit_3863948.png",
        "date": "2026-03-02 10:00:07",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 2 Mar 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The pharmaceutical company’s shares closed at ₹28.30, marking a significant intraday decline amid heightened volatility and unfilled supply, signalling growing investor apprehension in the micro-cap segment."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3854991",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3854991.png",
        "date": "2026-02-25 10:00:09",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 25 Feb 2026, reflecting intense selling pressure and panic among investors. The stock recorded a maximum daily loss of 4.97%, closing at ₹29.08, down ₹0.87 from the previous close, as unfilled supply overwhelmed demand in a micro-cap pharmaceutical sector stock already under significant bearish sentiment."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3844203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_mojoScore_3844203.png",
        "date": "2026-02-17 10:10:20",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mangalam Drugs Declines 2.07%: 5 Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-declines-207-5-key-events-shaping-the-week-3827532",
        "imagepath": "",
        "date": "2026-02-08 16:01:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Lower circuit hit amid heavy selling at Rs.32.68</p>\n                    <p><strong>3 Feb:</strong> Upper circuit triggered with strong buying at Rs.37.90</p>\n                    <p><strong>4 Feb:</strong> Lower circuit hit again closing at Rs.36.01</p>\n                    <p><strong>5 Feb:</strong> Consecutive lower circuit close at Rs.34.21</p>\n                    <p><strong>6 Feb:</strong> Week ends with lower circuit at Rs.32.50</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.36.29</div></div>\n                    <div class=\"stat-item..."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3823888",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3823888.png",
        "date": "2026-02-06 10:00:12",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 6 Feb 2026, closing at ₹32.5, down 5.0% on the day. The stock faced intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and unfilled supply. This marks the third consecutive day of declines, with the stock losing over 14% in that period, significantly underperforming its sector and the broader market."
      }
    ],
    "total": 178,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "06-Feb-2026",
      "details": "Outcome of Board meeting dated 6th February 2026 for change in management",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th February 2026",
      "datetime": "06-Feb-2026",
      "details": "Outcome of Board meeting",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for To Consider And Approve Appointment Of Chief Financial Officer Of The Company And Any Other Businesses.",
      "datetime": "04-Feb-2026",
      "details": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Board meeting to be held on 6th February 2026 to consider and approve appointment of Chief Financial Officer of the Company and any other Businesses.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-06 10:00:07

Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 6 Mar 2026, hitting the upper circuit limit of 5%, closing at ₹32.26. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and regulatory trading restrictions.

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-03-05 10:10:37

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-05 10:00:06

Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 5 Mar 2026, hitting the upper circuit limit of 5% to close at ₹30.73. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices despite subdued investor participation and a regulatory freeze on further price movement.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-04 11:00:04

Mangalam Drugs and Organics Ltd witnessed a robust surge in its share price on 4 Mar 2026, hitting the upper circuit limit of 5% and closing at ₹29.25. This sharp rally was driven by intense buying interest, resulting in a maximum daily gain of 4.97%, significantly outperforming its sector and benchmark indices despite opening with a gap down.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-03-02 10:00:07

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 2 Mar 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The pharmaceutical company’s shares closed at ₹28.30, marking a significant intraday decline amid heightened volatility and unfilled supply, signalling growing investor apprehension in the micro-cap segment.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-25 10:00:09

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 25 Feb 2026, reflecting intense selling pressure and panic among investors. The stock recorded a maximum daily loss of 4.97%, closing at ₹29.08, down ₹0.87 from the previous close, as unfilled supply overwhelmed demand in a micro-cap pharmaceutical sector stock already under significant bearish sentiment.

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-02-17 10:10:20

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Mangalam Drugs Declines 2.07%: 5 Key Events Shaping the Week

2026-02-08 16:01:16

Key Events This Week

2 Feb: Lower circuit hit amid heavy selling at Rs.32.68

3 Feb: Upper circuit triggered with strong buying at Rs.37.90

4 Feb: Lower circuit hit again closing at Rs.36.01

5 Feb: Consecutive lower circuit close at Rs.34.21

6 Feb: Week ends with lower circuit at Rs.32.50

Week Open

Rs.36.29

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-06 10:00:12

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 6 Feb 2026, closing at ₹32.5, down 5.0% on the day. The stock faced intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and unfilled supply. This marks the third consecutive day of declines, with the stock losing over 14% in that period, significantly underperforming its sector and the broader market.

Read full news article

View All News